PROM1 and lung adenocarcinoma: The flow cytometry analysis of cells isolated from the xenografts showed a remarkable increase of 7 and 35 times in the CD133+ population in lung adenocarcinoma cell line A549 and CD133-negative adenocarcinoma lung LT66 tumors, respectively, seven days after chemotherapy with cisplatin [182].